We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+0.17%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$3.81B
AUM Growth
+$1.88B
(+98%)
Cap. Flow
+$1.94B
Cap. Flow
% of AUM
50.99%
Top 10 Holdings %
Top 10 Hldgs %
5.52%
Holding
3,983
New
1,493
Increased
1,108
Reduced
652
Closed
727
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$25.6M |
| 2 |
JPMorgan Chase
JPM
|
+$21.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$19.7M |
| 4 |
Kroger
KR
|
+$17.9M |
| 5 |
T-Mobile US
TMUS
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$11.3M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$8.42M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$8.34M |
| 4 |
Cisco
CSCO
|
+$8.02M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$8.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.84% |
| 2 | Technology | 16.54% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 11.32% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KNRX
3101
Knorex Ltd
KNRX
$14.5M
| $16.6K | ﹤0.01% |
+10,643
| New | +$20.6K |
|
3102
Cheetah Net Supply Chain Service
CTNT
$5.97M
| $16.4K | ﹤0.01% |
+70
| New | +$21K |
|
|
MIMI
3103
Mint Inc
MIMI
$12.1M
| $16.2K | ﹤0.01% |
+5,385
| New | +$156K |
|
3104
ClearSign Technologies
CLIR
$25.5M
| $16.1K | ﹤0.01% |
+2,902
| New | +$23.1K |
|
|
SYBX
3105
DELISTED
Synlogic
SYBX
| $16.1K | ﹤0.01% |
14,398
+3,225
| +29% | +$4.83K |
|
3106
Destination XL Group
DXLG
$34.3M
| $16.1K | ﹤0.01% |
+17,498
| New | +$18K |
|
|
SFHG
3107
Samfine Creation Holdings
SFHG
$10.1M
| $16K | ﹤0.01% |
+4,347
| New | +$13.2K |
|
3108
ParaZero Technologies
PRZO
$11.5M
| $15.9K | ﹤0.01% |
+19,569
| New | +$27K |
|
|
LGVN
3109
Longeveron
LGVN
$19M
| $15.9K | ﹤0.01% |
+31,476
| New | +$22.1K |
|
|
ENGS
3110
Energys Group
ENGS
$88.1M
| $15.8K | ﹤0.01% |
+18,562
| New | +$74.9K |
|
3111
KALA BIO
KALA
$12.3M
| $15.7K | ﹤0.01% |
+566
| New | +$25.3K |
|
3112
ZK International Group
ZKIN
$70.5M
| $15.7K | ﹤0.01% |
+10,469
| New | +$23.5K |
|
|
CAPT
3113
DELISTED
Captivision
CAPT
| $15.5K | ﹤0.01% |
45,282
+1,796
| +4% | +$1.28K |
|
3114
Scienjoy Holding
SJ
$39.1M
| $15.5K | ﹤0.01% |
22,339
+4,859
| +28% | +$2.85K |
|
|
ALUR
3115
DELISTED
Allurion Technologies
ALUR
| $15.5K | ﹤0.01% |
12,577
+351
| +3% | +$589 |
|
|
NINE
3116
DELISTED
Nine Energy Service
NINE
| $15.5K | ﹤0.01% |
44,751
+18,452
| +70% | +$9.11K |
|
3117
My Size
MYSZ
$2.02M
| $15.3K | ﹤0.01% |
20,219
+9,984
| +98% | +$10.5K |
|
3118
Retractable Technologies
RVP
$20.1M
| $15.3K | ﹤0.01% |
19,837
+5,288
| +36% | +$4.56K |
|
3119
Century Therapeutics
IPSC
$370M
| $15.3K | ﹤0.01% |
15,333
-12,225
| -44% | -$7.46K |
|
|
HCAI
3120
Huachen AI Parking Management Technology
HCAI
$5.64M
| $15K | ﹤0.01% |
1,448
+1,082
| +296% | +$15.6K |
|
|
FAT
3121
DELISTED
FAT Brands
FAT
| $15K | ﹤0.01% |
+47,558
| New | +$57K |
|
|
BMGL
3122
Basel Medical
BMGL
$9.97M
| $14.9K | ﹤0.01% |
+2,536
| New | +$37.4K |
|
3123
Cocrystal Pharma
COCP
$12.9M
| $14.8K | ﹤0.01% |
+15,141
| New | +$16K |
|
3124
Silynxcom
SYNX
$6.77M
| $14.8K | ﹤0.01% |
13,846
+3,720
| +37% | +$4.95K |
|
|
YYGH
3125
YY Group Holding Ltd
YYGH
$3.91M
| $14.8K | ﹤0.01% |
49
+29
| +145% | +$12.1K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q4 2025 Portfolio in Review
As of Q4 2025, XTX Topco held 3,983 positions worth $3.81B, up 98% from $1.93B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
XTX Topco deployed $1.94B of net new capital in Q4 2025, opening 1,493 new positions and adding to 1,108 existing holdings. Its largest new stake was T-Mobile US: 74,738 shares worth $15.2M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.34M trimmed.
- XTX Topco's largest Q4 2025 buy was T-Mobile US: 74,738 shares worth $15.2M.
- XTX Topco added most to Procter & Gamble in Q4 2025, an estimated $25.6M increase.
- XTX Topco's biggest Q4 2025 reduction was Bristol-Myers Squibb, cutting an estimated $8.34M.
- XTX Topco fully exited Johnson & Johnson in Q4 2025, selling an estimated $11.3M.
- XTX Topco's ten largest holdings make up 5.5% of its $3.81B portfolio in Q4 2025.
- XTX Topco opened 1,493 new positions and closed 727 in Q4 2025.
- XTX Topco's portfolio value rose 98% quarter-over-quarter to $3.81B.
Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.